Table 3 Agreement (κ coefficient) using CD4 count obtained by flow cytometry, CD4 percent by computational estimate, and total lymphocyte count (TLC) compared to CD4 percent obtained by flow cytometry for children not eligible for ART on clinical grounds, i.e. WHO stage I or II
Age group | n | CD4 count | CD4 percent computational estimate | TLC |
|---|---|---|---|---|
Overall | 170/125* | 77.6% (0.39) | 87.6% (0.71) | 64.8% (0.04)* |
≤ 11 months | 41 | 78.0% (0.19) | 87.8% (0.63) | 80.5% (0.32) |
12 to 35 months | 22 | 68.2% (0.32) | 95.4% (0.91) | 54.5% (0.02) |
36 to 59 months | 21 | 71.4% (0.25) | 71.4% (0.35) | 47.6% (-0.32) |
60 months to 96 months | 41 | 85.4% (0.58) | 92.7% (0.82) | 63.4% (0.04) |
≥ 96 months | 45 | 77.8% (0.45) | 86.7% (0.71) | N/A† |